These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 37852044)

  • 1. Degeneration of cholinergic white matter pathways and nucleus basalis of Meynert in individuals with objective subtle cognitive impairment.
    Qiu T; Hong H; Zeng Q; Luo X; Wang X; Xu X; Xie F; Li X; Li K; Huang P; Dai S; Zhang M;
    Neurobiol Aging; 2023 Dec; 132():198-208. PubMed ID: 37852044
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lateral thinking: Neurodegeneration of the cortical cholinergic system in Alzheimer's disease.
    Crockett RA; Casselton C; Howard TM; Wilkins KB; Seo G; Brontë-Stewart HM;
    Neurobiol Dis; 2024 Oct; 201():106677. PubMed ID: 39307400
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cholinergic white matter pathways in dementia with Lewy bodies and Alzheimer's disease.
    Schumacher J; Ray NJ; Hamilton CA; Donaghy PC; Firbank M; Roberts G; Allan L; Durcan R; Barnett N; O'Brien JT; Taylor JP; Thomas AJ
    Brain; 2022 Jun; 145(5):1773-1784. PubMed ID: 34605858
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cholinergic white matter pathways make a stronger contribution to attention and memory in normal aging than cerebrovascular health and nucleus basalis of Meynert.
    Nemy M; Cedres N; Grothe MJ; Muehlboeck JS; Lindberg O; Nedelska Z; Stepankova O; Vyslouzilova L; Eriksdotter M; Barroso J; Teipel S; Westman E; Ferreira D
    Neuroimage; 2020 May; 211():116607. PubMed ID: 32035186
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cholinergic white matter pathways along the Alzheimer's disease continuum.
    Nemy M; Dyrba M; Brosseron F; Buerger K; Dechent P; Dobisch L; Ewers M; Fliessbach K; Glanz W; Goerss D; Heneka MT; Hetzer S; Incesoy EI; Janowitz D; Kilimann I; Laske C; Maier F; Munk MH; Perneczky R; Peters O; Preis L; Priller J; Rauchmann BS; Röske S; Roy N; Scheffler K; Schneider A; Schott BH; Spottke A; Spruth EJ; Wagner M; Wiltfang J; Yakupov R; Eriksdotter M; Westman E; Stepankova O; Vyslouzilova L; Düzel E; Jessen F; Teipel SJ; Ferreira D
    Brain; 2023 May; 146(5):2075-2088. PubMed ID: 36288546
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of cerebral small vessel disease on the integrity of cholinergic system in mild cognitive impairment patients: a longitudinal study.
    Qiu T; Hong H; Zeng Q; Xu X; Wang Y; Zhu L; Zhang L; Li K; Dai S; Li X; Xie F; Zhang Y; Luo X;
    J Neurol; 2024 May; 271(5):2704-2715. PubMed ID: 38381177
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Degeneration in Nucleus basalis of Meynert signals earliest stage of Alzheimer's disease progression.
    Shafiee N; Fonov V; Dadar M; Spreng RN; Collins DL
    Neurobiol Aging; 2024 Jul; 139():54-63. PubMed ID: 38608458
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nucleus Basalis of Meynert Degeneration Predicts Cognitive Decline in Corticobasal Syndrome.
    Urso D; Nigro S; Tafuri B; De Blasi R; Pereira JB; Logroscino G;
    Biol Psychiatry; 2024 Jun; 95(11):1048-1054. PubMed ID: 38309321
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neuropsychiatric symptoms of cholinergic deficiency occur with degradation of the projections from the nucleus basalis of Meynert.
    van Dalen JW; Caan MWA; van Gool WA; Richard E
    Brain Imaging Behav; 2017 Dec; 11(6):1707-1719. PubMed ID: 27787708
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nucleus basalis of Meynert degeneration predicts cognitive impairment in Parkinson's disease.
    Wilson H; de Natale ER; Politis M
    Handb Clin Neurol; 2021; 179():189-205. PubMed ID: 34225962
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Are Linear Measurements of the Nucleus Basalis of Meynert Suitable as a Diagnostic Biomarker in Mild Cognitive Impairment and Alzheimer Disease?
    Jethwa KD; Dhillon P; Meng D; Auer DP;
    AJNR Am J Neuroradiol; 2019 Dec; 40(12):2039-2044. PubMed ID: 31727757
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pretangle pathology within cholinergic nucleus basalis neurons coincides with neurotrophic and neurotransmitter receptor gene dysregulation during the progression of Alzheimer's disease.
    Tiernan CT; Ginsberg SD; He B; Ward SM; Guillozet-Bongaarts AL; Kanaan NM; Mufson EJ; Counts SE
    Neurobiol Dis; 2018 Sep; 117():125-136. PubMed ID: 29859871
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structural degeneration of the nucleus basalis of Meynert in mild cognitive impairment and Alzheimer's disease - Evidence from an MRI-based meta-analysis.
    Mieling M; Meier H; Bunzeck N
    Neurosci Biobehav Rev; 2023 Nov; 154():105393. PubMed ID: 37717861
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HDAC2 dysregulation in the nucleus basalis of Meynert during the progression of Alzheimer's disease.
    Mahady L; Nadeem M; Malek-Ahmadi M; Chen K; Perez SE; Mufson EJ
    Neuropathol Appl Neurobiol; 2019 Jun; 45(4):380-397. PubMed ID: 30252960
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vivo nucleus basalis of Meynert degeneration in mild cognitive impairment with Lewy bodies.
    Schumacher J; Taylor JP; Hamilton CA; Firbank M; Cromarty RA; Donaghy PC; Roberts G; Allan L; Lloyd J; Durcan R; Barnett N; O'Brien JT; Thomas AJ
    Neuroimage Clin; 2021; 30():102604. PubMed ID: 33711623
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Postural and gait symptoms in de novo Parkinson's disease patients correlate with cholinergic white matter pathology.
    Nazmuddin M; van Dalen JW; Borra RJH; Stormezand GN; van der Horn HJ; van der Zee S; Boertien J; van Laar T
    Parkinsonism Relat Disord; 2021 Dec; 93():43-49. PubMed ID: 34784526
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Basal forebrain volume reliably predicts the cortical spread of Alzheimer's degeneration.
    Fernández-Cabello S; Kronbichler M; Van Dijk KRA; Goodman JA; Spreng RN; Schmitz TW;
    Brain; 2020 Mar; 143(3):993-1009. PubMed ID: 32203580
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MicroRNA-132 and early growth response-1 in nucleus basalis of Meynert during the course of Alzheimer's disease.
    Zhu QB; Unmehopa U; Bossers K; Hu YT; Verwer R; Balesar R; Zhao J; Bao AM; Swaab D
    Brain; 2016 Mar; 139(Pt 3):908-21. PubMed ID: 26792551
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nucleus basalis of Meynert damage and cognition in patients with multiple sclerosis.
    Hildesheim FE; Benedict RHB; Zivadinov R; Dwyer MG; Fuchs T; Jakimovski D; Weinstock-Guttman B; Bergsland N
    J Neurol; 2021 Dec; 268(12):4796-4808. PubMed ID: 33997915
    [TBL] [Abstract][Full Text] [Related]  

  • 20. No laughing white matter: Reduced integrity of the cortical cholinergic pathways in Parkinson's disease-related cognitive impairment.
    Crockett RA; Wilkins KB; Aditham S; Brontë-Stewart HM
    Neurobiol Dis; 2023 Sep; 185():106243. PubMed ID: 37524210
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.